376 related articles for article (PubMed ID: 6307052)
1. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
Hensleigh PA
Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
[TBL] [Abstract][Full Text] [Related]
2. Antepartum Rh immune globulin.
Wible-Kant J; Beer AE
Clin Perinatol; 1983 Jun; 10(2):343-55. PubMed ID: 6311476
[TBL] [Abstract][Full Text] [Related]
3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
4. Prevention of Rh alloimmunization.
Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
[TBL] [Abstract][Full Text] [Related]
5. Rh negative status and isoimmunization update: a case-based approach to care.
Harrod KS; Hanson L; VandeVusse L; Heywood P
J Perinat Neonatal Nurs; 2003; 17(3):166-78; quiz 179-80. PubMed ID: 12959478
[TBL] [Abstract][Full Text] [Related]
6. Utilization of Rh prophylaxis.
Berger GS; Keith L
Clin Obstet Gynecol; 1982 Jun; 25(2):267-75. PubMed ID: 6179676
[TBL] [Abstract][Full Text] [Related]
7. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
Maas DH; Schneider J
Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
Vŭlcheva B; Spasova K
Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
[No Abstract] [Full Text] [Related]
9. Reversal of Rh alloimmunization. Fact or fancy?
Bowman JM; Pollock JM
Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
[TBL] [Abstract][Full Text] [Related]
10. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
11. Cost implications of routine antenatal administration of Rh immune globulin.
Adams MM; Marks JS; Koplan JP
Am J Obstet Gynecol; 1984 Jul; 149(6):633-8. PubMed ID: 6331166
[TBL] [Abstract][Full Text] [Related]
12. Total prevention of Rh hemolytic disease: possible or impossible?
Bowman JM
Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
[TBL] [Abstract][Full Text] [Related]
13. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
15. Detection and quantitation of fetomaternal hemorrhage.
Turner WA; Fadel HE; Krauss JS
South Med J; 1986 May; 79(5):571-5. PubMed ID: 3010476
[TBL] [Abstract][Full Text] [Related]
16. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
Crane JP; Rohland B; Larson D
Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
[TBL] [Abstract][Full Text] [Related]
17. The use of Rh immune globulin: a review.
Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
[No Abstract] [Full Text] [Related]
18. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient.
Judd WJ; Luban NL; Ness PM; Silberstein LE; Stroup M; Widmann FK
Transfusion; 1990 Feb; 30(2):175-83. PubMed ID: 2154871
[No Abstract] [Full Text] [Related]
19. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women.
Stedman CM; Baudin JC; White CA; Cooper ES
Am J Obstet Gynecol; 1986 Jun; 154(6):1363-9. PubMed ID: 3013010
[TBL] [Abstract][Full Text] [Related]
20. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
Baskett TF; Parsons ML; Peddle LJ
CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
